Canopy Growth Corporation (TSX:WEED)
1.800
-0.260 (-12.62%)
Aug 15, 2025, 4:00 PM EDT
Canopy Growth Revenue
Canopy Growth had revenue of 72.13M CAD in the quarter ending June 30, 2025, with 8.94% growth. This brings the company's revenue in the last twelve months to 274.92M, down -4.24% year-over-year. In the fiscal year ending March 31, 2025, Canopy Growth had annual revenue of 269.00M, down -9.47%.
Revenue (ttm)
274.92M
Revenue Growth
-4.24%
P/S Ratio
1.57
Revenue / Employee
286.37K
Employees
960
Market Cap
431.73M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Curaleaf Holdings | 1.75B |
Green Thumb Industries | 1.57B |
Trulieve Cannabis | 1.62B |
Sienna Senior Living | 929.68M |
dentalcorp Holdings | 1.62B |
Cronos Group | 177.69M |
WELL Health Technologies | 1.10B |
Extendicare | 1.51B |
Canopy Growth News
- 20 hours ago - Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now - Business Wire
- 4 days ago - Tilray Surges 14% After Hours On Trump Cannabis Reclassification - Benzinga
- 4 days ago - Canopy Growth Rallies On News Of Possible Rescheduling From Trump - Seeking Alpha
- 4 days ago - Cannabis stocks soar on Trump reclassification speculation - Invezz
- 4 days ago - Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification - CNBC
- 7 days ago - Canopy Growth Corporation (CGC) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Adult-Use Cannabis Boom Powers Canopy Growth Sales, But Wider Loss Hits Margins - Benzinga
- 7 days ago - Canopy Growth posts Q1 beat thanks to strong cannabis sales - Seeking Alpha